🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking fines, prosecution or prison.

Service Response and Content Removal

According to the social media company, the service has taken down violative material and banned associated keywords and search suggestions. The organization said it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.

Within minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.

Item Information and Costs

Within these groups, posts display dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Although the research behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious medical dangers”.